The need for a population-based surveillance system for liver disease in the United States.

Pharmacoepidemiol Drug Saf

Novartis, Inc., Senior Epidemiologist, Clinical Safety and Epidemiology, One Health Plaza, East Hanover, NJ, USA.

Published: November 2004

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.1022DOI Listing

Publication Analysis

Top Keywords

population-based surveillance
4
surveillance system
4
system liver
4
liver disease
4
disease united
4
united states
4
population-based
1
system
1
liver
1
disease
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!